iPS cells and iN cells

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The discovery of iPS indicated that overexpression of master transcriptional factors might change cell fate. Recent developments in reprogramming methods have shown that somatic cells can be directly reprogrammed to various kinds of neuronal cells directly. Moreover, overexpression of a neuron-specific transcriptional factor with a viral vector can change the fate of endogenous glial cells to neuronal cells in vivo. In this chapter, we discuss the advantages, issues, and possibility for clinical application of these reprogramming methods for cell transplantation/replacement therapy.

Original languageEnglish
Title of host publicationCell Therapy against Cerebral Stroke
Subtitle of host publicationComprehensive Reviews for Translational Researches and Clinical Trials
PublisherSpringer Japan
Pages39-46
Number of pages8
ISBN (Electronic)9784431560593
ISBN (Print)9784431560579
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Neurons
Cell Transplantation
Neuroglia
Therapeutics

Keywords

  • Cerebral ischemia
  • In vivo direct reprogramming
  • iNCs
  • iNSCs
  • iPSCs
  • Stroke

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Yamashita, T., & Abe, K. (2017). iPS cells and iN cells. In Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials (pp. 39-46). Springer Japan. https://doi.org/10.1007/978-4-431-56059-3_4

iPS cells and iN cells. / Yamashita, Toru; Abe, Koji.

Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials. Springer Japan, 2017. p. 39-46.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yamashita, T & Abe, K 2017, iPS cells and iN cells. in Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials. Springer Japan, pp. 39-46. https://doi.org/10.1007/978-4-431-56059-3_4
Yamashita T, Abe K. iPS cells and iN cells. In Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials. Springer Japan. 2017. p. 39-46 https://doi.org/10.1007/978-4-431-56059-3_4
Yamashita, Toru ; Abe, Koji. / iPS cells and iN cells. Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials. Springer Japan, 2017. pp. 39-46
@inbook{2c34e46d70f349358fd89000ada803cc,
title = "iPS cells and iN cells",
abstract = "The discovery of iPS indicated that overexpression of master transcriptional factors might change cell fate. Recent developments in reprogramming methods have shown that somatic cells can be directly reprogrammed to various kinds of neuronal cells directly. Moreover, overexpression of a neuron-specific transcriptional factor with a viral vector can change the fate of endogenous glial cells to neuronal cells in vivo. In this chapter, we discuss the advantages, issues, and possibility for clinical application of these reprogramming methods for cell transplantation/replacement therapy.",
keywords = "Cerebral ischemia, In vivo direct reprogramming, iNCs, iNSCs, iPSCs, Stroke",
author = "Toru Yamashita and Koji Abe",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-4-431-56059-3_4",
language = "English",
isbn = "9784431560579",
pages = "39--46",
booktitle = "Cell Therapy against Cerebral Stroke",
publisher = "Springer Japan",

}

TY - CHAP

T1 - iPS cells and iN cells

AU - Yamashita, Toru

AU - Abe, Koji

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The discovery of iPS indicated that overexpression of master transcriptional factors might change cell fate. Recent developments in reprogramming methods have shown that somatic cells can be directly reprogrammed to various kinds of neuronal cells directly. Moreover, overexpression of a neuron-specific transcriptional factor with a viral vector can change the fate of endogenous glial cells to neuronal cells in vivo. In this chapter, we discuss the advantages, issues, and possibility for clinical application of these reprogramming methods for cell transplantation/replacement therapy.

AB - The discovery of iPS indicated that overexpression of master transcriptional factors might change cell fate. Recent developments in reprogramming methods have shown that somatic cells can be directly reprogrammed to various kinds of neuronal cells directly. Moreover, overexpression of a neuron-specific transcriptional factor with a viral vector can change the fate of endogenous glial cells to neuronal cells in vivo. In this chapter, we discuss the advantages, issues, and possibility for clinical application of these reprogramming methods for cell transplantation/replacement therapy.

KW - Cerebral ischemia

KW - In vivo direct reprogramming

KW - iNCs

KW - iNSCs

KW - iPSCs

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85026538029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026538029&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-56059-3_4

DO - 10.1007/978-4-431-56059-3_4

M3 - Chapter

AN - SCOPUS:85026538029

SN - 9784431560579

SP - 39

EP - 46

BT - Cell Therapy against Cerebral Stroke

PB - Springer Japan

ER -